“ASSESSING THE LEADER TRIAL: UNDERSTANDING MYOCARDIAL INFARCTION SUBTYPES IN TYPE 2 DIABETES MELLITUS PATIENTS AND THE BENEFICIAL IMPACT OF LIRAGLUTIDE THERAPY”. 2023. Student’s Journal of Health Research Africa 4 (12): 5. https://doi.org/10.51168/sjhrafrica.v4i12.865.